Quebec University in Laval, Canada. This is the first tricuspid valve replacement in Canada

The Institut universitaire de cardiologie et de pneumologie de Québec–Université Laval (the Institute) recently successfully performed a first case of percutaneous tricuspid replacement. So far, only 10 patients worldwide have undergone this type of percutaneous replacement. The procedure was performed by Dr. François Dagenais, cardiac surgeon and head of the Cardiac Surgery Service and by Dr. Josep Rodés-Cabau, hemodynamicist and researcher at the Research Center.

Tricuspid insufficiency is a common disease in patients with heart valve damage. In the presence of significant tricuspid leakage, the probability of mortality increases if it is not corrected. However, isolated tricuspid valve surgery remains infrequent but is associated with operative morbidity and mortality. The vast majority of patients with severe tricuspid leak therefore remain medically treated or are referred for surgery at a late stage with right ventricular dilation and dysfunction. During the last years,

The NaviGate bioprosthesis (NaviGate Cardiac Structures Inc., Laguna Hills, CA, USA) is the only available device that has been used to completely replace the native tricuspid valve in humans. The first case of percutaneous tricuspid replacement in Canada was performed at the Institute on February 2 in a 79-year-old patient with severe symptomatic tricuspid regurgitation at high surgical risk. The procedure went well with no immediate complications, with an excellent end result. The patient is currently continuing his convalescence with a satisfactory evolution, and will be discharged from the hospital in the next few days.

To see video, please click here

ABOUT THE INSTITUTE – IUCPQ.qc.ca

Every year, 15,3961 people are hospitalized there and 122,257 visits are carried out on an outpatient basis for 43,268 users. The catchment area amounts to more than 2 million inhabitants, or about 30% of the population of Quebec. Affiliated with Laval University, the establishment relies on the collaboration and dedication of more than 3,000 employees, doctors, professionals, researchers, managers and volunteers to provide quality care and services to hospitalized and ambulatory clients. In particular, the Institute offers specialized and ultra-specialized care and service programs for the treatment of cardiovascular and respiratory diseases and diseases related to obesity. The physicians and health professionals at the Institute have extensive expertise and contribute to advancing the science of medicine. The Institute also has the mission of evaluating technologies and methods of health intervention. The Institute`s Research Center is internationally recognized for the quality of its research.

ABOUT THE RESEARCH CENTER

The Research Center`s vision is to be a key international player in the fight against chronic societal diseases through its integrated research model in cardiology, pulmonology and obesity. The Research Center relies on the collaboration of 171 researchers and medical researchers, many of whom are recognized as leaders in their field. These internationally renowned researchers are among the most productive in Quebec. In addition, the perfect alignment of research areas with the specializations of the Institute ensures synergy between clinicians and researchers, thus allowing rapid transfer of knowledge to care.